Skip to main content
. 2019 Mar 18;7(3):48. doi: 10.3390/medsci7030048

Figure 4.

Figure 4

Partial response of an 85-year-old patient with pleomorphic rhabdomyosarcoma treated with pazopanib as first-line therapy. PET scans before (a) and at 8 weeks after (b) pazopanib show significant shrinkage of the primary tumor in the right shoulder as well as of the lung metastasis, as indicated by the red arrows.